Platelet-derived microparticles (MP) are reported to express both pro-and anticoagulant activities. Nevertheless, their functional significance has remained unresolved. The present study monitored the generation and fate of MP in an experimental model of thrombosis with costimulation of platelets by collagen and thrombin. When minimally anticoagulated (0.5 pmol/L PPACK) blood was perfused over immobilized fibrillar type I collagen in a flow chamber at a low shear rate (300 s-'1, endogenous thrombin was generated, as evidenced by thrombin-antithrombin 111 complex. In contrast to full anticoagulation (50 pmol/L PPACK) and the ab sence of collagen, large platelet aggregates and fibrin ensued during perfusions over collagen in the presence of HE RELEASE OF vesicles or microparticles (MP) from T platelets follows their activation by strong agonists, such as thrombin and collagen, or the increase in intracellular calcium concentration induced either by complement C5b-9 proteins, or calcium ionophore.'-3 These vesicles have been reported to possess both procoagulant',2 and anti~oagulant~.~ activities due to the negative charge derived from exposed membrane phosphatidylserine phospholipids. It has been reported that in contrast to platelet membranes, the procoagulant activity is enriched and retained on the surface of MP?3.6.7 Procoagulant surface is lost from platelets by the action of platelet phosphoaminotranslocase, which is either inactive or lacking from MP.8 Suggestive of a hemostatic role, factor XII19 and several of the platelet surface glycoprotein (GP) receptorsI0-" have been shown to reside on MP. Studies on MP have predominantly assessed their biochemical properties in solution. Additionally, the conditions under which MP form and the characteristics of their surface antigens have been analyzed by flow ~y t o m e t r y . '~, '~.~~ Increased concentrations of MP have been detected in association with clinical thrombotic conditions, such as idiopathic thrombocytopenic purpura,I5 transient ischemic attacks, and thrombotic strokesL6 However, the functional significance of MP is still largely unknown, and their generation under conditions that mimic those of in vivo hemostasis and thrombosis has not been established.
buffer." Nine volumes of blood were collected in one volume of the anticoagulant. Blood collected in 131 mmoVL acidic citrated dextrose (pH 4 . 3 , at a ratio of one volume to six volumes of blood, was used for preparing gel-filtered platelets from which MP were generated in vitro.
Preparation of tissue culture slides with immobilized collagen. Plastic Permanox (Nunc, Roskilde, Denmark) tissue culture slides were coated with fibrillar collagen type I (equine). Collagen solution (1 mg/mL) was repeatedly smeared on the slides to an approximate final density of 3 pglcm. ' The surface was soaked with N-tris(hydroxy-methyl)-methyl-2-aminoethanesulfonic acid (Sigma) buffer (pH 7.4), and the slides were incubated at 35°C for 90 minutes to form native-type fibrils in
The coated slides were stored in a moist atmosphere and used during the same day.
Assessment of thrombin generation and a-granule release during whole blood perfusion. Whole blood clotting time (WBCT) was developed to monitor ongoing coagulation before and during the perfusion. Immediately after sampling, 100 pL of bovine a-thrombin (5 U/mL) was added to 200 pL of whole blood at 37°C in an Amelung Coagulometer (KC 1A, H. Amelung GMBH, Lemgo, Germany). The thrombin concentration was selected to yield a clotting time shorter than 120 seconds to enable the repeated examination of samples during the 5-minute perfusion. Also, samples for prothrombin fragment 1 and 2 (F,,'), thrombin-antithrombin 111 (TAT) complex, and plasminogen activator inhibitor-1 antigen (PAI-I ) were taken to monitor the course of the perfusion. The increase of PAI-1, an a-granule protein, in plasma was considered as a marker reflecting platelet activation and subsequent release reaction. The samples (900 pL) for TAT were taken into ice-cold 13 1 mmol/L sodium citrate (100 pL), centrifuged (12,OOOg, 10 minutes), and the plasma was stored at -20°C. To stabilize platelets, PAI-I samples were collected and subsequently handled according to suggested standards." All samples were thawed by a brief warming at 37"C, and were assayed with commercial enzyme-linked immunosorbent assay (ELISA) kits (Enzygnost F, +' and Enzygnost TAT, Behring; TintElize PAL I , Biopool, Umei, Sweden). F l t z samples were analyzed from PAI-I plasma. Equal TAT results were obtained from citrated and PAI-I plasma. Normal values of F,,, are < 1.1 nmol/L, of TAT <4.0 ng/ mL, and of PAI-I vary between 4 to 40 ng/mL. Induction of thrombin by whole blood perjiusion over immobilized collagen. Whole blood perfusion was performed using the Badimon perfusion chamber with defined rheological characteristics.''. '4 Platelet and white blood cell count and hematocrit were determined by Thrombocounter Coulter T-540 (Coulter Electronics, Inc, Hialeah, FL). From each donor, three to four sequential perfusions (SO mL of O S pmoVL PPACK -anticoagulated blood) were performed, each over a new collagen-coated slide. This approach was chosen to provide, at least in one of the perfusions, a thrombus comprised of platelet aggregates and fibrin, but without too dense multilayered fibrin coverage. As a criterion, the first perfusion was started when WBCT had shortened < I O 0 seconds. At that time, platelet count had remained unchanged. The blood aliquot was prewarmed at 37°C for 5 minutes. The collagen-coated slide was exposed to a singlepassage blood flow at a shear rate of 300 s~' for 5 minutes. Afterwards, the slide was shortly perfused with phosphate-buffered saline (PBS). On removal, the slide was rinsed with ice-cold PBS and subjected to various microscopic analyses. Subsequent perfusions with a new blood aliquot each time were undertaken immediately after the first perfusion. Blood anticoagulated with 50 pmoUL PPACK was perfused as a control.
The perfused slide was divided into sections that were reacted with 5 pg/mL MoAbs (m7E3, CLB-6, and X63, as a negative control) in 3% bovine serum albumin (BSA)-PBS for I hour on ice. The samples were washed with icecold PBS and fixed in ice-cold 1% paraformaldehyde-PBS for I hour while the temperature rose to 22°C. After washing, the samples Immunofluorescence microscopy.
were blocked with rabbit serum in 3% BSA-PBS, treated with TRITC-conjugated rabbit antimouse antibody ( I :SO) for 30 minutes, and then rinsed and mounted in glyceroWBS (pH 8.0). Some of the samples were double-stained to detect fibrin(ogen) and GPIIbIIIa or P-selectin. After incubation with the relevant MoAb and TRITCconjugated rabbit antimouse antibody, the slides were incubated with FITC-conjugated rabbit immunoglobulins against fibrin(ogen) ( 1 :SO) in 3% BSA-PBS. The samples were examined using a Zeiss epifluorescence microscope (Carl Zeiss, Inc, Thornwood, NY), and photographed with Agfa 1000 Rx color reversal film.
Scanning electron microscopy (SEM) and scanning immunoelectron microscopy (immuno-SEM). Perfusion samples for immuno-SEM were treated as described for immunofluorescence microscopy except for the following modifications. The secondary antibody was substituted with colloidal gold-conjugated (GAR-10) goat antimouse antibody, incubated for 30 minutes at 22"C, and rinsed thoroughly. The immuno-SEM and SEM samples were fixed with 2.5% glutaraldehyde-PBS for 2 hours at 22°C. For immuno-SEM, the slides were then subjected to a silver enhancement procedurezs according to the manufacturer's instructions. The samples underwent alcohol drying, critical point-drying with COz, and sputter-coating with gold for SEM or with carbon for immuno-SEM. The samples were examined with a JEOL Scanning Microscope 820 in SEM or a Zeiss Digital Scanning Microscope 962 in immuno-SEM at the Department of Electron Microscopy, University of Helsinki (Helsinki, Finland). In immuno-SEM, the antibody-bound silver was localized by backscattered electron images, and confirmed by x-ray microanalysis based on the characteristic x-ray lines of different elements.'" Using a Link Isis energy dispersive spectrometer (Oxford Instruments LTD. Oxford, UK), the specifically deposited silver, incorporated over the gold-conjugated antibody, could be distinguished from the background, which derived from uneven topography and carbon-coating of the samples and tungsten from the silver enhancement procedure (data not shown). In contrast, only nonspecifically deposited tungsten was detected in X63-samples, the negative control.
Gel-tiltered platelets were prepared from platelet rich plasma essentially as previously reported to avoid plasma proteins and platelet washing." Platelets were eluted through a Sepharose CL-2B column (Pharmacia LKB Biotechnology Inc, Uppsala, Sweden), and MP were generated with various agonists under stimng for 5 minutes in the presence of 2 m m o K CaCIZ. The agonists were bovine a-thrombin (0.25 U/ mL), collagen (10 pg/mL), thrombin and collagen together, and calcium ionophore A23187 ( I O pmol/L). When thrombin was used, 40 pmol/L PPACK was added 60 seconds after the induction to block the proteolysis of platelet receptors." As a control, platelets were also treated similarly, but without an agonist (data not shown). A supernatant containing M P was separated from platelet remnants by centrifugation at 15,OOOg for 2 minutes,I4 and the centrifugation step was repeated until platelet count was < 1 X 10' mL.
Determination qf microparticle-fibrin(ogen1 binding in vitro. ELISA-plates (EB-Combiplate, Instrumentarium, Helsinki, Finland) were coated with fibrin(ogen),2y collagen:" and vWF," and blocked with 2% BSA-PBS. A total of 100 pL of MP induced with various agonists, or MP remaining after preincubation over the separately generated fibrin matricies, or unstimulated platelets with known platelet count as a control, were incubated in duplicate wells for I hour at 37°C. The bound MP were detected with MoAb m7E3 (1 :300 in 1 % BSA-PBS) and peroxidase-conjugated goat antimouse antibody (1:1750 in 1% BSA-PBS). Color was developed by using TMB Peroxidase Substrate (Kirkegaard & Perry Laboratories Inc. Gaithersburg, ML). Absorbance was measured at 450 nm with Labsystems Multiscan MCC (Labsystems, Helsinki, Finland).
Fibrin matrices were generated separately to study the binding of MP to fibrin originating either from isolated human fibrinogen (2 mg/mL in 10 mmoln Tris, 0.15 mmoVL NaCI, pH 7.8) or citrated
In vitro generation of platelet-derived micropurticles.
For personal use only. on October 27, 2017. by guest www.bloodjournal.org From (90 mmoVL) plasma. Matricies were generated in equal volumes in 24-well flat bottom multidishes (Nunc). Fibrin from fibrinogen was generated in the presence of 2 mmom CaC12 and human a-thrombin (0.9 U/mL) and fibrin from plasma was generated by recalcification (4 mmolR. CaC12) and treatment with thrombin as mentioned above. The matricies were incubated at 37°C for 30 minutes. Thrombin was blocked with PPACK (40 pmollL). The wells were blocked with 2% BSA-PBS. In vitro -generated MP were incubated at 37°C over various fibrin matrices. One hour thereafter, the remaining MP were collected and analyzed by ELISA with a fibrinogen coating.
Assessment of the procoagulant activiv of the matrix-bound MP. The matrix-bound MP generated by calcium ionophore from 300 X 106/mL platelets were compared with the matrix-bound platelets (1 or 300 x 106/mL) in a procoagulant assay measuring thrombin activity. Round plastic Thermanox coverslips (Nunc) were coated with collagen or fibrin prepared from recalcified citrated plasma, as reported above, except omitting PPACK. Fibrin was also induced by reptilase with a coagulant activity corresponding to that of thrombin (1U of bovine a-thrombidcoverslip). After allowing MP, platelets, or buffer control to adhere to collagen or fibrin(s) (30 minutes, 37°C) in 24-well multidishes, the slides were washed with PBS and incubated (15 minutes, 37°C) with citrated platelet-poor plasma (1:20 dilution in PBS with CaCI,; GIBCO, Paisley, Scotland, UK) and tissue factor (1:5,000 dilution of Thromborel S). After the collection of supernatants and the addition of S-2238, the reaction was terminated with 20% acetic acid at selected time points. The absorbance due to the generated thrombin activity was measured at 405 nm.
Embolectomy samples were obtained from nine patients treated for an acute lower limb arterial occlusion in the Department of Vascular Surgery at the Helsinki University Central Hospital. The embolectomy specimens were taken within 24 hours of the onset of symptoms. The specimens were snap-frozen and stored under liquid nitrogen before processing for immunohistochemical peroxidase staining. Fresh frozen sections were fixed with cold acetone (-20°C) for 10 minutes and rinsed in PBS. Immunohistochemical stainings were performed using the ABC complex/HRP method (Dakopatts NS).
Data were expressed as mean 5 standard deviation (SD), unless otherwise indicated. Regression analysis was used for the correlation coefficients. The Student's t-test was used for comparison of two groups of data and analysis of variance within multiple groups.
Immunohistochemistry of in vivo thrombi.
Statistical analysis.

RESULTS
The experimental conditions f o r platelet-derived microparticle generation during whole blood perfiisions. In this study, the generation and fate of platelet-derived MP during thrombus formation was evaluated by providing the experimental prerequisite for effective platelet stimulation. Because a combination of collagen and thrombin is known to induce extensive MP f o r m a t i~n ,~,~.~~ the experiment was designed to provide these stimuli as native as possible, ie, with immobilized fibrillar collagen and endogenous thrombin. Platelets were exposed to a collagen-coated tissue culture slide in flowing blood under low-shear rate conditions. The extent of anticoagulation was varied by collecting blood in a 100-fold concentration range of the specific thrombin inhibitor, PPACK. The low concentration of PPACK (0.5 pmol/L) used at blood collection, provided conditions under which platelet-activating and fibrin-forming thrombin was generated on the perfused surface and in the blood (Fig 1) .
By contrast, 50 pmol/L PPACK fully inactivated thrombin and was used as a control in corresponding perfusions.
The design of minimal anticoagulation and sequential perfusions was aimed at generating enough thrombin for platelet activation and microvesiculation, but avoiding such excessive thrombin formation, which would result in a multilayered structure hindering morphological observations of the thrombus. During the sequential perfusions with 0.5 pmoV L PPACK-blood from the same donor, coagulation in response to endogenous thrombin was continuously monitored with various parameters. The individual course of perfusions in which MP were detected by immunofluorescence microscopy varied, as illustrated in three representative examples from different donors (Fig 1) . While perfusing, WBCT showed a significant shortening (Fig lA) , ie, during perfusion WBCT always decreased more than in the blood aliquots waiting to be perfused. The decrease of WBCT (37.5% 2 7.3%) was twice the decrease (17.5% 2 9.3%) simultaneously occurring in the blood reservoir measured from the three successive perfusions from three different donors (P = .005), implying that the blood contact with collagen hastened the overcoming of the anticoagulation capacity of PPACK. During each perfusion, platelet count declined profoundly in the blood that had just passed the chamber ( Fig   1B) . The decline in platelet count (65% t-21%), measured in the three successive perfusions from the three different donors, was significant when compared with the decline occurring in the blood reservoir (P < .005). Simultaneously, reflecting the formation of platelet (micro)aggregates in the blood, white blood cell count increased (data not shown). Thrombin generation progressed during perfusion, based on the F1+2 and TAT values (Fig IC and D) . WBCT, which was the only plausible variable to monitor blood coagulation during the experiment, correlated with TAT (correlation coefficient, r = 0.75, P < .02), and with platelet count ( r = .76, P = .02), but did not associate with F,,,. The concentration of PAI-1 tended to increase in the final samples compared with those taken before the perfusion (Fig 1E) . However, the increase was only modest, as was the increase of F,,,. In contrast to minimal anticoagulation, in fully anticoagulated (50 pmol/L PPACK) perfusions, all the variables remained essentially unchanged throughout the experiment (Fig 1) . Probably due to the perfusion per se, an initial decline of platelet count was observed, but because thrombin was not generated, platelet count did not decline further.
As the 100-fold range of anticoagulation resulted in various degrees of thrombin generation and platelet activation, the morphology of the corresponding thrombi was analyzed in SEM. Also, we compared the costimulation by collagen and thrombin together with the stimulation induced by either collagen or thrombin alone (Fig 2) . A view of a collagencoated slide after a perfusion with minimally anticoagulated (0.5 pmol/L PPACK) blood and endogenous thrombin generation displayed the different components of a thrombus formed under costimulatory conditions (Fig 2A) . Platelet aggregates and fibrin deposition with entrapped red blood cells were abundant and also single collagen-adherent platelets could be detected. Usually, at the end of a 5-minute perfusion (as described in Fig I) , the surface of the thrombus was covered with fibrin (see Fig 3A) . For comparison, when collagen was the only platelet agonist present in fully anticoagulated (50 pmol/L PPACK) perfusions, fibrin and red blood cells were lacking, and the size of deposited platelet
For personal use only. on October 27, 2017. by guest www.bloodjournal.org From aggregates was smaller (Fig 2B) . If the perfusion slide was not coated with collagen, but the blood was minimally anticoagulated (0.5 pmoVL PPACK) enabling excessive thrombin generation, a single layer of adhering platelets spread on the slide, and fibrin was not detected (Fig 2C) . The finding that aggregates were lacking demonstrated the need of collagen-induced platelet activation resulting in platelet recruitment, as pictured in Fig 2A. Thus, the stimulation of platelets by both limited anticoagulation and immobilized collagen resulted in markedly enhanced thrombus formation compared with either of the stimuli alone. Localization and analysis of platelet-derived microparticles generated during thrombosis under minimal blood anticoagulation. The SEM-analysis of the slides, perfused under the costimulatory conditions for 5 minutes, showed even fibrin deposition, covering underlying platelet aggregates (Fig 3A) . Additionally, occasional new aggregates with interconnecting multistranded fibrin cables developed over this surface. MP were searched by various microscopic techniques from these samples with evident platelet activation. The morphological analysis of the thrombi by SEM under high magnification showed small (< 1 pm) granular particles associating with platelet aggregates (Fig 3B) . Similar particles were also adherent to multistranded fibrils of fibrin ( Fig  3C) . Cables of fibrin strands projecting from platelet aggregates were overlaid by granular particles that presumably originated from these aggregates (Fig 3D) . The particles observed by SEM appeared to represent MP generated during thrombus formation. In contrast, the surface of platelet aggregates generated during perfusions with full anticoagulation was devoid of granular particles, but showed multiple developing pseudopods (Fig 3E) .
To show that the granular particles were of platelet origin, the thrombi were analyzed by immunofluorescence microscopy for two different platelet-derived markers reported to be present on the surface of MP.".'' GPIIbIIIa (CD41/ recognized by the MoAb m7E3, was selected as a MP marker for its abundance. P-selectin (CD62). a glycoprotein member of the selectin family, was chosen as a MP marker coinciding with platelet activation and associated a-granule fusion. Pselectin was recognized by the MoAb CLB-6. Analysis of the thrombi using both MP markers verified that the small. granular, strandlike material was platelet-derived (Fig 4A  and C) , and the size of this material was smaller than could be expected for an adhering platelet. As a control, similar samples were reacted with MoAb X63 and were negative (not shown). Double-staining of the samples for fibrin (ogen) and GPIIbIIla or P-selectin, verified that the platelet-derived material resided along fibrin (Fig 4B and D) . In immunofluorescence microscopy, the single-stranded fibrin network covering the thrombus seemed devoid of this material. Instead, P-selectin-and GPlIbIIIa-positive material was most often detected binding to multistranded fibrin cables that originated from platelet aggregates or connected two aggregates. sometimes even considerable distances apart (Fig 4B  and D) .
Although indicative, neither SEM nor immunofluorescence microscopy by itself was specific enough to ascertain
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whether the observed granular particles were MP. Therefore, immuno-SEM with x-ray microanalysis was used both to confirm their platelet origin and to aid in differentiating these particles from platelet remnants persisting after activation. The perfusion procedure and the subsequent staining were similar as in immunofluorescence microscopy, except a goldconjugated secondary antibody (GAR-IO) was used. To accommodate the requirements of SEM (Fig SA) , a silver enhancement procedure was applied to further increase the backscattered electron signal of gold." In a backscattered electron micrograph, the silver-enhanced emission signal localized platelets and small granular dots ( < I pm) along thrombi generated during the whole blood perfusion. During perfusion under minimal anticoagulation, fibrinenmeshed plate let aggregates formed over immobilized collagen while thrombin was generated. Scanning electron micrographs of (AI the surface of the thrombus at the end of a 5-minute perfusion (0.5 pmollL PPACKl covered with even fibrin network. Note the layered structure of underlying aggregates (arrows) and t o p most occasional aggregates connected by multistranded fibrin cables, (B) small granular particles ( 4 pm) on the surface of a platelet aggregate surrounded by fibrin and enmeshed red blood cells, (C) granular particles overlaying a fibrin bundle, (DI granular particles covering both the platelet aggregate, and the multistranded fibrin cable protruding from it, (E) the surface of a platelet aggregate at the end of a control perfusion (50 pmoll L PPACK). Note the multiple pseudopods and the absence of granular particles. In (A), bar = 10 pm, B through E, bar = 1 pm. fibrin (Fig SB) . The size of these particles varied, starting from approximately 100 nm. Unlike in immunofluorescence microscopy, the granules were also seen to bind to the singlestranded network of fibrin. However, the localization of these particles in the single-stranded fibrin network tended to be close to a possible origin of vesiculation (a platelet or an aggregate). X-ray microanalysis of the platelet and small shining dots in the backscattered electron-micrograph ( Fig   SB) showed peaks for silver at their characteristic energy levels," verifying the presence of MoAbs (Fig SC) . When 25 backscattered electron -positive particles, regarded as MP, were analyzed with x-ray microanalysis, 19 were found posiFor personal use only. on October 27, 2017. by guest www.bloodjournal.org From C D Fig 4. lmmunolocalization of platelet-derived small granules and fibrin in thrombi generated during the whole blood perfusion with minimal anticoagulation. The perfusion samples were stained with MoAbs against platelet GPllbllla (m7E3) and P-selectin (CLB-6). MoAbs were visualized in immunofluorescence microscopy with TRITC-conjugated rabbit antimouse antibody. For double-labeling studies, fibrin(ogen) was traced with FITC-conjugated polyclonal rabbit immunoglobulins against human fibrin(ogen). Epifluorescence micrographs of (A) two strongly stained platelet aggregates connected with a narrow m7E3-positive strand, (B) the same location as in (A), but stained with FITC-conjugated antibody against fibrinlogen), indicating fibrin, (C) a partly CLB-6-positive fibril protruding from a platelet aggregate, and (D) the same location as in (C) showing the FITC-positive fibrin fibril, which aligned with the P-selectin containing material. Bar = 5 pm.
tive for silver. Ten corresponding spots (platelets and MP) of the samples treated with control MoAb X63 were also xray microanalyzed, and all were devoid of silver. The peaks, if any, showed only the presence of tungsten in the X63-samples. In conclusion, immuno-SEM and x-ray microanalysis confirmed that the particles adhering to fibrin in the thrombi both contained the platelet-specific markers, GPIIbIIIa and P-selectin, and were, although variable in size, smaller than platelets, thus verifying the particles as plateletderived MP. The analysis of these thrombi with immuno-SEM and x-ray-analysis was possible only in selected areas devoid of multilayered structure, whereby quantitative evaluation of MP would have been biased.
Analysis of microparticle binding to jibrin(ogen) in vitro.
Because the morphological evidence indicated that MP adhered to fibrin during thrombus formation, the ability of MP to bind to fibrin(ogen) was tested in vitro with ELISA. Also, different substrates representing subendothelial components, namely collagen and vWF, were compared with fibrin(ogen).
For this purpose, MP were generated in vitro by various agonists and separated from platelet remnants. MP were found to bind better to fibrin(ogen) than to collagen or to vWF (Table 1) . MP generated by various stimuli differed when assessed by fibrin(ogen)-binding. The costimulation of platelets by thrombin and collagen produced more fibrinogen-binding MP than either of these stimuli alone (data not shown). The most fibrinogen-binding MP were induced with calcium ionophore A23187 (Table 1) . Also, the ability of ionophore-generated and matrix-bound MP to act as a procoagulant surface was assessed ( Table 2) . MP, bound to either thrombin-or reptilase-generated fibrin, were found to catalyse thrombin activity better than 1 X 10' mL platelets, being more compatible with the amount of thrombin activity generated by 300 X 106/mL platelets bound to fibrin under identical conditions. Also, the procoagulant activity of fibrinbound MP clearly exceeded the activity of MP adherent to collagen.
To determine the conditions under which in vitro-gener- The binding capacity of the two types of MP was analyzed with the MoAb m7E3 in ELISA. The binding of MP is presented as arbitrary units calculated by dividing the absorbances in the MP samples with the absorbance in a control sample of gel-filtered platelets (1 x lo6/ mL) adhering to fibrinogen under the same conditions. Data are presented as mean f SE, (n = 4). MP adhered significantly more to fibrinogen and fibrin than to either vWF ( P < .03, paired t-test) or to collagen ( P < .OZ. paired t-test).
ated MP bound to fibrin, an ELISA-based two-phase protocol was developed. Fibrin was generated either from plasma or purified fibrinogen to study how these fibrins affected the binding. MP, induced by thrombin plus collagen or calcium ionophore, readily bound to fibrin generated from recalcified human plasma in comparison with the fibrin generated from fibrinogen. The preincubation of MP over plasma-derived fibrin resulted in SS% t 14% (thrombin plus collagen) or 31% 2 10% (calcium ionophore) decrease in fibrinogenbinding MP in ELISA, if compared with MP suspensions subjected to ELISA without preincubation (n = 5 ) . RGDS and KQAGDV, established blockers of fibrinogen-binding domains of GPIIbIIIa, were used to study the role of GPIlbllla in MP-fibrin(ogen) interactions. Both RGDS and KQAGDV (90 pmol/L) partially inhibited MP binding to fibrin(ogen) by 44% 2 0.4%. The degree of inhibition was not affected by the peptides at an increased concentration (290 pmol/L), which has been reported to block platelet adhesion.3' Taken together, in vitro studies of MP-binding confirmed the capacity of MP to adhere to fibrin and to promote thrombin generation there.
In addition to in vitro thrombosis experiments, we analyzed whether and where MP could be detected in thromboemboli generated Itnmimohistochernistn of in vivo thrombi. For The procoagulative capacity of fibrin-or collagen-adherent platelets and MP (induced with calcium ionophore A23187 from 300 x 10' mL platelets) was analyzed with a chromogenic assay. After incubating (15 minutes, 37°C) diluted plasma and tissue factor over the matrixbound MP or platelets, supernatants were collected and the chromogenic substrate s-2238 was added. The generated thrombin activity was measured after 6 minutes. Data are from a single experiment representative of three separate experiments.
in vivo. Fresh (<24 hours) samples were obtained during embolectomy from patients suffering an acute lower limb arterial occlusion. The typical morphology of layers of tangled fibrin strands and of platelet aggregates was detected in the analyzed thrombi (Fig 6) . In immunohistochemistry, these strands were decorated with MoAb T2G1 (Fig 6A) , recognizing the amino acids 15-42 in BP-fragment of fibrin 11, known to predominate in a mature thrombus.34 Plateletspecific MoAbs, m7E3 and CLB-6, visualized large platelet aggregates containing GPIIbIIIa (Fig 6C and D) and P-selectin (Fig 6E) , respectively. In areas among platelet aggregates, fine granular GPIIbIIIa-and P-selectin-specific staining was detected in a stranded pattern, suggestive of an alignment with fibrin (Fig 6C, D, and E) . The size of this GPIIbIIIaand P-selectin-positive material was in accordance with particles smaller than platelets. These findings imply the adherence of MP to fibrin also during thrombus formation in vivo.
DISCUSSION
The functional significance of MP has remained vague. This is despite their pro-and anticoagulative properties,3-6.8 and the convincing evidence that MP surface possesses platelet-subendothelium attachment receptors (GPIIbIIIa, Ib, IaIIa),'O-l' and P-selectin," a receptor involved in platelet-leukocyte interactions35336 and in inflammatory response~.~' In the present study, the formation of MP was detected in whole blood perfusion experiments tailored to mimic thrombosis. MP were shown to bind to the forming thrombus and specifically to fibrin. Similar morphological features of the MP-containing fibrin could be detected also in embolectomized thrombi.
In in vitro perfusion experiments, the generation of thrombin and the subsequent development of thrombi were slowed down by a thrombin inhibitor. PPACK was specifically chosen because it allows relatively extensive formation of fibrin, due to an unoccupied fibrinoged-binding site in PPACKthrombin.38 In the presence of excessive thrombin generation during perfusions over collagen, MP could be detected when the thrombus had progressed to a stage where large platelet aggregates connected with multistranded fibrin cables. However, the layered morphology of the thrombus restricted the detection so that quantitation of the thrombus-bound MP was impossible. In the absence of fibrin (Fig 2B and C) , we could not detect MP. This implies that the docking sites for MP were lacking, but does not exclude the possibility that MP were generated. MP, ranging in size from 100 nm upwards, were observed in accordance with previous res u l t~.~~*~ If coagulation proceeded further, the fully evolved thrombi were covered with dense fibrin mesh and masses of red blood cells that masked the underlying morphology. Therefore, the use of nonanticoagulated blood with thrombin formation compatible to ours would probably have further hampered the search for MP using immunofluorescence microscopy and SEM. 4' In an evolving in vitro thrombus, multistranded fibrin cables were overlaid by MP, while they seemed scarce on the uppermost layer of the singlestranded fibrin network. This morphological feature of the association between multistranded fibrin cables and MP, or more correctly plateletderived material incompatible with the size of platelets, predominated in immunofluorescence microscopy and SEM (magnifications below l0,OOO). Also, immunofluorescence microscopy could not necessarily distinguish MP from platelet remnants, or platelet pseudopods reported to extend along fibrin during clot retraction?' Even in immuno-SEM, where size still is the only feasible discriminator among plateletderived particles, this differentiation could not be absolute. However, the sensitization obtained with silver enhancement technique in SEM25 at higher magnifications strongly suggested that these particles represent MP, and that MP may also bind the single-stranded fibrin network. This morphological diversity between immunofluorescence microscopy/ SEM and immuno-SEM was probably due to the different detection limits of these techniques, For instance, in immunofluorescence microscopy, a sufficient amount of MP bound to fibrin strands in close proximity to one another (forming a multistranded cable) could create a signal strong enough for detection.
The morphological association of MP and fibrin was further confirmed by ELISA. Furthermore, the thrombin generation assay verified that fibrin-bound MP function as procoagulants, and may thereby increase and sustain the catalytic surfaces present in the thrombus. MP bound to both fibrinogen and fibrin better than to vWF and collagen, which may explain why MP were scarce in experiments using vWF and collagen as MP-binding substrates." The quantity of fibrin(ogen)-binding MP coincided with the reported MPinducing potential of the respective agonists'*'*3' and did not necessarily reflect qualitative differences of the MP. Fibrin generated from recalcified plasma turned out to be an optimal MP-binding matrix. It is difficult, however, to draw conclusions on the fibrin(ogen) preference of MP based on ELISA, as both the isolated MP and the produced fibrin are likely to differ from the ones generated during thrombosis either in vitro or in vivo. The relative inability of GPIIbIIIa receptorblocking peptides to inhibit MP-fibrin(ogen) binding may indicate that additional binding determinants exist either on the surface of MP or in fibrin(~gen)!~ Such a candidate on MP could well be GPIb (CD42b), shown to participate in platelet-fibrin interactions. 44 Only two experimental studies, namely the detection of For personal use only. on October 27, 2017. by guest www.bloodjournal.org From For personal use only. on October 27, 2017. by guest www.bloodjournal.org From infused MP in a bleeding time wound4' and the attachment of isolated MP on s~bendothelium~~ have suggested a hemostatic function for MP. On the other hand, the role of MP was questioned in a study where exogenous thrombin was used to stimulate adherent platelets on either vWF or on monomeric collagen under static condition^.'^ Simulating whole blood response to vessel wall injury by native-type collagen and endogenous thrombin offered a novel model to study the appearance and fate of MP. This model provided both rheological conditions with the possible contribution of all blood cells and strong activation of platelets by collagen and timely thrombin, which developed fibrin within the forming thrombus. Because the use of different shear rate conditions is known to modulate the morphology and extent of a thrombus,""' a shear rate of 300 s-I was used to allow the recruitment of not only fibrin, but also platelets, a source of MP.
The use of markers reflecting coagulation and platelet activation enabled us to characterize the conditions that favored the appearance of MP. While perfusing, WBCT was the only feasible marker of the extent of anticoagulation, but because WBCT correlated well with TAT, it was a reliable indicator of progressive thrombin generation. Under those perfusion conditions where MP were found, WBCT declined in parallel with platelet count. The decrease in platelet count implied both the deposition of platelets to the thrombus and (micro) aggregate formation in the blood. The finding of the modest increase in PAI-1 agrees with the concept of PAI-1 being retained in the fibrin of the evolving thrombus.48 Even though PAL1 did not significantly increase, P-selectin was expressed, and thus we concluded that these perfusions resulted in platelet activation, aggregation, and generation of MP. In fully anticoagulated control experiments, the resulting platelet aggregates were small, fibrin was absent, and a closer analysis did not disclose the presence of MP. Taken together, our morphological findings are in accordance with the established concept that thrombin is mandatory for thrombus growth and stability to induce maximal platelet interaction with collagen, arterial media, and subendothelium,41 ,49,50 In addition to thrombin, different collagens have been shown to affect the extent and characteristics of platelet a~tivation?~.~* For example, nonanticoagulated blood in contact with pepsin-treated collagen type 111, did not induce fibrin in the thrombus.53 However, compared with our setup, in this study, less thrombin was generated before the blood contacted with the collagen. The regulatory role of collagen in activating platelets under flow conditions was demonstrated-even with excessive thrombin-by the distinct morphological features in the presence as opposed to the absence of collagen (Fig 2A and C) .
Evidence for the involvement of MP in hemostasis is highlighted by Scott's syndrome, a disease manifested by occasional bleeding.54 In this disease, the patient's platelets are unable to microvesiculate, and blood coagulation and the generation of fibrin are impaired.47 The data presented here provide a local adhesive function for MP in a developing thrombus. The presence of MP-containing fibrin among platelet aggregates in the experimental thrombus coincided in embolectomized thrombi. Combining our morphological finding with the known aspects of MP, the fibrin-bound MP could modulate thrombus formation by providing sustained catalytic surfaces for coagulation factors and their regulaIn addition to the hemostatic implications, MP by adhering to local fibrin, could mediate monocyteheutrophilfibrin interactions in inflammation through P-~electin.~' Presently, these interactions have only been characterized at the molecular level without considering platelets affecting the structure of fibrin. Taken together, the presented issues support the existence and functional role of MP in thrombosis and hemostasis.
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